Isis Pharma (ISIS) Earns $1.5M Milestone for ISIS-GSK4Rx Program Advancement
Tweet Send to a Friend
Isis Pharma (NASDAQ: ISIS) has earned a $1.5 million milestone payment from GSK related to the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
